课题基金 / 基金详情

Preventive measure of the development of hepatocellular carcinoma by hepatitis C virus infection

Preventive measure of the development of hepatocellular carcinoma by hepatitis C virus infection
丙型肝炎病毒感染引起肝细胞癌的预防措施
批准号:
12212001
负责人:
SHIMOTOHNO Kunitada
金额:
$44.93万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2004

项目摘要

项目成果

SHIMOTOHNO Kunitada的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatitis C virus (HCV) is a causative agent for the development of chronic hepatitis. HCV infection is also shown to be an important agent for the development of hepatocellular carcinoma, but the precise mechanism for the development of these diseases remains to be elucidated. Current researches suggest the significant roles of HCV proteins on the disease progression. Thus, I have conducted experiments to analyze the roles of HCV protein on regulation of cell proliferation and disclosed the following evidence ; (1) HCV core protein has potential, to enhance NF-kB signaling, (2) HCV core protein enhances RARa dependent transcription by way of sequestration of transcriptional suppressor protein Sp110b, (3) HCV NS5A protein has function to regulate PKR by the interaction with PKR through the almost two-thirds of NS5A protein. For the preventive measure of HCV infection as well as for eradication of HCV from infected individuals, analysis of HCV genome replication in HCV genome self-replicating cells was conducted. And the following new finding was made by the analysis ; (1) replication of HCV genome seems to be conducted in a complex protected by ER derived membrane, which mainly localizes on ER, (2) replication of the HCV genome is strictly regulated by innate immunity signaling, in particular, those activated by TLR3, (3) HCV genome replication is positively regulated by cyclophilin B. Some of these information may be applicable for the development of a new agent with anti-HCV function.
期刊论文(76)
专著(0)
科研奖励(0)
会议论文
Kato N, et al.: "Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro"Biochem Biophys Res Commun.. 306. 756-766 (2003)
Kato N 等:“源自体外感染的人肝细胞的丙型肝炎病毒亚基因组复制子的建立”Biochem Biophys Res Commun.. 306. 756-766 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ueda Y, et al.: "Wnt/b-catenin signaling suppresses apoptosis in low serum medium and induces morphological change in rodent fibroblasts"Int.J.Cancer. 99. 681-688 (2002)
Ueda Y 等人:“Wnt/b-连环蛋白信号传导抑制低血清培养基中的细胞凋亡并诱导啮齿动物成纤维细胞的形态变化”Int.J.Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Cytoplasmic localization is important for transcription factor nuclear factor-kappa B activation by hepatitis C virus core protein though its amino terminal region.
细胞质定位对于丙型肝炎病毒核心蛋白通过其氨基末端区域激活转录因子核因子-κB 很重要。
DOI: --
发表时间: 2001
期刊: Virology 286
影响因子: --
作者: [Kishine H, Sugiyama K, Hijikata M, Kato N, Takahashi H, Noshi T, Nio Y, Hosaka M, Miyanari Y, Shimotohno K., Watashi K.et al.]
通讯作者: Watashi K.et al.
Watashi K, et al.: "K.The roles of hepatitis C virus proteins in modulation of cellular functions : A novel action mechanism of the HCV core protein on gene regulation by nuclear hormone receptors"Cancer Sci. 94. 937-943 (2003)
Watashi K 等人:“K.丙型肝炎病毒蛋白在细胞功能调节中的作用:HCV 核心蛋白对核激素受体基因调节的新作用机制”Cancer Sci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
34
    The role of lipid metabolism on HCV proliferation
    Roles of lipid in HCV production
    • 批准号:
      20390135
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.9万
    • 财政年份:
      2008
    • 负责人:
      SHIMOTOHNO Kunitada
    • 依托单位:
    Development of preventive measures of liver failures caused by HCV infection by clarification of the mechanisms of liver diseases
    The roles of Tax encoded by HTLV on cell proliferation
    • 批准号:
      16390135
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2004
    • 负责人:
      SHIMOTOHNO Kunitada
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: